» Articles » PMID: 10476719

Nosocomial Bloodstream Infections in United States Hospitals: a Three-year Analysis

Overview
Journal Clin Infect Dis
Date 1999 Sep 7
PMID 10476719
Citations 343
Authors
Affiliations
Soon will be listed here.
Abstract

Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.

Citing Articles

A screen to identify antifungal antagonists reveals a variety of pharmacotherapies induce echinocandin tolerance in .

Reitler P, DeJarnette C, Kumar R, Tucker K, Peters T, Twarog N bioRxiv. 2025; .

PMID: 40027746 PMC: 11870487. DOI: 10.1101/2025.02.18.638903.


Ribosome profiling reveals differences in global translational vs transcriptional gene expression changes during early biofilm formation.

Mundodi V, Choudhary S, Smith A, Kadosh D Microbiol Spectr. 2025; 13(3):e0219524.

PMID: 39873514 PMC: 11878023. DOI: 10.1128/spectrum.02195-24.


Structure-guided design and synthesis of C22- and C32-modified FK520 analogs with enhanced activity against human pathogenic fungi.

Dome P, Jeong P, Nam G, Jang H, Rivera A, Floyd Averette A Proc Natl Acad Sci U S A. 2024; 122(1):e2419883121.

PMID: 39739817 PMC: 11725869. DOI: 10.1073/pnas.2419883121.


The pathogenicity and virulence of the opportunistic pathogen .

Burke O, Zeden M, OGara J Virulence. 2024; 15(1):2359483.

PMID: 38868991 PMC: 11178275. DOI: 10.1080/21505594.2024.2359483.


A Comprehensive Review of Identification Methods for Pathogenic Yeasts: Challenges and Approaches.

Morovati H, Kord M, Ahmadikia K, Eslami S, Hemmatzadeh M, Kurdestani K Adv Biomed Res. 2023; 12:187.

PMID: 37694259 PMC: 10492613. DOI: 10.4103/abr.abr_375_22.